Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards and Value-Based Oncology Care to Patients
Collaborating to Improve Quality of Cancer Care
NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced today its new customer, Wexford Health Sources, Inc. (Wexford Health). Wexford Health, the nation's leading innovative correctional health care company, chose Eviti® Connect, NantHealth’s evidence-based treatment intelligence and web-based oncology decision support platform, to ensure inmates receive appropriate care for their oncologic conditions.
“As we continually improve our comprehensive medical program, it’s important for us to do so with the well-being of our patients in mind,” said Dr. Tom Lehman, CCHP, CCHP-P, Corporate Medical Director of Wexford Health. “High costs and high mortality illnesses are prevalent in our nation’s correctional facilities. By collaborating with NantHealth and their Eviti Connect solution, we are now able to streamline oncology authorization allowing patients to begin evidence-based treatment quickly.”
Wexford Health is a recognized leader in providing experienced management and technologically-advanced services, combined with programs that control costs and ensure quality. As one of the nation’s largest correctional healthcare companies, they provide a full range of medical, behavioral health, pharmacy, utilization management, provider contracting, claims processing, and quality management services. The relationship with NantHealth will allow Wexford Health to continue to build upon their commitment to quality care and technology advancement.
“According to a 2009 study published in the American Journal of Public Health, about 40% of the nation’s prison and jail population reported a chronic medical condition such as cancer,” said Dr. Sandeep “Bobby” Reddy, Chief Medical Officer of NantHealth. “Wexford Health is setting an example for others to follow by gaining visibility into the cost of care at the regimen level before patient treatment begins and informing treatment decisions with a comprehensive, evidence-based clinical library.”
NantHealth’s Eviti Connect platform helps ensure that cancer treatment plans are aligned with evidence-based medicine to support high quality patient care. With Eviti Connect, providers can receive treatment authorizations in a timely fashion so patients can begin treatment without delay.
